Our Commitment

Naniniwala kami rito sa RiteMed na ang lahat ng Pilipino ay may karapatang gumaling. Ito ang aming paninindigan kung kaya’t sinisikap naming gawing abot-kaya ang mga dekalidad na gamot na kailangan ng bawat Pilipino.

 

Upang masiguro ang kalidad ng aming mga gamot, ginagawa namin ang mga ito sa Amherst Laboratories, ang pinaka-advanced na pharmaceutical plant sa Asya. Kinukuha rin namin ang iba naming mga produkto mula sa mga mapapagkatiwalaang kumpanya upang maging available ang mahahalagang gamot sa abot-kayang halaga. Ngunit higit pa sa paggawa ng mga dekalidad at abot-kayang gamot, tungkulin namin sa bawat Pilipino na tumulong sa paghubog sa isang malusog at malakas na bansa. Dahil dito, layunin naming ipaabot sa lahat ng Pilipino ang kanilang karapatan sa magandang kalusugan.

 

Our Vision

Patient

To make our products and services available to majority of households.

 

Employees

To be the preferred source of dynamic talents in the corporate organization.

 

Doctors and Allied Professionals

To enrich the profession of our partners in the medical community by helping them achieve patient compliance.

 

Community

To make our products and services available to majority of households.

 

Trade

To be the vehicle in fulfilling the social commitment of Unilab to the Filipino people.

 

To the Shareholders

To be the biggest market share contributor in the pharma business of unilab.

 

Our History

RiteMED was formed in 2002 by United Laboratories Inc. (Unilab) in response to the government's efforts to promote generics as an affordable option for Filipino patients. The objective was to offer a portfolio of unibranded (i.e., single brand) generic medicines with the same quality as the product-branded ones in order to generate trust among doctors and other healthcare professionals.

 

RiteMED has since become the leading unibranded generic company in the country. It enabled the United Health Group, of which RiteMED is a member company, to launch generic counterparts of various molecules at lower prices due to the lower cost of promoting only one company brand, instead of multiple product brands. RiteMED's tag line “Right Medicine, Priced Right” encapsulates what it wants to achieve.

 

With the initial support of doctors and other healthcare professionals, RiteMED rapidly expanded its product offerings from 2002 to 2010. Aside from the original antibiotics, vitamins and pain relievers, RiteMED started to make available a few cardiovascular, respiratory, and anti-allergy products. It focused its marketing efforts on generating trust among medical doctors to encourage them to prescribe RiteMED, especially to patients who could barely afford the more expensive product-branded medicines.

 

In September 2009, however, RiteMED faced a serious business reversal when the government imposed the Maximum Drug Retail Price and asked other companies to reduce their prices voluntarily under the Government-Mediated Access Price (GMAP) program. These twin moves resulted in a price squeeze as pharmaceutical companies reduced their prices because of, or in response to, MDRP and GMAP. In 2010, the first full year of the reduced drug prices, RiteMED suffered a huge financial loss and had to transfer most of its medical representatives to other Unilab marketing divisions to prevent them from being retrenched.

 

In the following year, with a total workforce of only thirty-four (34) employees and with no money to support a marketing field force, RiteMED had to revise its business model. It transformed itself from a conventional pharma company that covers doctors to secure prescriptions into an advocacy brand that speaks directly to patients and actively helps them assert their right to affordable and quality healthcare products and services. RiteMED launched the “Bawal ang Mahal” campaign and engaged the services of Ms. Susan Roces as brand ambassador to deliver one key message -- quality medicines need not be expensive. It sought to subvert the dominant paradigm of “Bawal Magkasakit . . . dahil mahal magkasakit”.

 

The “Bawal ang Mahal” was successful, especially coming after the Department of Health explained to the public that many of the medicine brands familiar to them and which they have been using for years are in fact brands of generic medicines. While they are medicines products with brands, they are nevertheless generic because they are not being marketed by companies that developed them. The campaign was also instrumental in developing the confidence of drugstore chains to carry RiteMED products despite not having the prescription support that conventional pharmaceutical companies have.

 

With Ms. Susan Roces as its brand ambassador, the original campaign was followed by a series of marketing campaigns (“May Karapatan Kang Gumaling”, “Gusto Naming Gumaling Kayo”, and “Dasal Naming Gumaling Kayo”), all emphasizing the right of every Filipinos to have access to quality essential medicines. enabling them to exercise their constitutional right to affordable healthcare products and services. It continues to increase its product portfolio so Filipino patients can have access to RiteMED medicines regardless of their disease. In partnership with drugstores, doctors, pharmacists, and other healthcare professionals, RiteMED promises to be by their side with right medicines that are priced right.

 

Our Partners